GeneReach Biotechnology Corp. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 323.42 million compared to TWD 277.11 million a year ago. Revenue was TWD 323.25 million compared to TWD 275.58 million a year ago. Net income was TWD 137.16 million compared to TWD 109.73 million a year ago. Basic earnings per share from continuing operations was TWD 2.3855 compared to TWD 1.9127 a year ago. Diluted earnings per share from continuing operations was TWD 2.3127 compared to TWD 1.9055 a year ago.
For the six months, sales was TWD 559.15 million compared to TWD 510.35 million a year ago. Revenue was TWD 558.93 million compared to TWD 508.13 million a year ago. Net income was TWD 236.98 million compared to TWD 202.78 million a year ago. Basic earnings per share from continuing operations was TWD 4.1236 compared to TWD 3.5273 a year ago. Diluted earnings per share from continuing operations was TWD 3.9782 compared to TWD 3.52 a year ago.